Athersys, Inc. (ATHX) Tops Q2 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. SPY
2. NVDA
3. PTC
4. META
5. PCVX
6. USO
7. MSFT
8. AMD
9. ATH
10. KLC

Go back to Athersys, Inc. (ATHX) Tops Q2 EPS by 10c

Athersys Reports Second Quarter 2014 Results

August 11, 2014 4:05 PM EDT

CLEVELAND, Aug. 11, 2014 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) today announced its financial results for the three months ended June 30, 2014. Highlights of the second quarter of 2014 and recent events include:

Advanced enrollment of Phase 2 clinical trial of MultiStem® cell therapy for treatment of ischemic stroke, expecting to complete enrollment in the next several months with initial top-line results following analysis of patient data collected through 90 days after treatment; Progressed preparations for Phase 2 acute myocardial infarction (AMI) study targeted to be launched later this year; Continued interactions with Pfizer regarding the... More